BioXcel Therapeutics, Inc. - Special Call Transcript
Hello and welcome to the BioXcel Therapeutics conference call. (Operator Instructions) As a reminder, this conference is being recorded. (Operator Instructions)
It's now my pleasure to turn the call over to CEO, Vimal Mehta. Please go ahead, sir.
Thank you, operator. Good morning, everyone, and thank you for joining our conference call today to discuss the top line results from our 2 pivotal Phase III SERENITY trial. We appreciate everyone's time and attention, and hope that you and your loved ones are staying safe. A press release announcing these results crossed the wire earlier today and is available on BioXcel Therapeutics website.
As a reminder, we will be making forward-looking statements regarding our financial outlook in addition to regulatory product development and commercialization plan. Such forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, and actual results may
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |